International Journal of Risk and Safety in Medicine
International Journal of Risk and Safety in Medicine is a journal indexed in SJR in Medicine (miscellaneous) and Public Health, Environmental and Occupational Health with an H index of 29. It has a price of 2395 €. It has an SJR impact factor of 0,251 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,251.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
0,251
H-index
29
Docs (year)
29
Docs 3y
118
Total refs
1043
Cites 3y
104
Citable 3y
108
Cites/Doc 2y
0.88
Ref/Doc
35.97
Immediate OA
2395 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Antidepressant-induced suicide, violence and mania: Risks for military personnel
View moreUnexpected aggressive behaviour: Interaction of bupropion and alcohol
View moreDrug use in pregnancy in the county of North Jutland -preliminary analyses based on 6142 pregnancies
View moreDrug regulation and the tradition of secrecy
View moreDirect-to-physician and direct-to-consumer advertising: Time to have stringent regulations
View moreDiagnostic methods in complementary medicine. Which craft is witchcraft?
View moreDeveloping a model for hospital inherent safety assessment: Conceptualization and validation
View moreDeterminants of sleep habits in toddlers: Application of planned behavior theory
View moreClinical conferences for physicians: Who sets the agenda?
View moreClassifying improvements to drug marketing and justifications for claims of efficacy
View moreCervical manipulation: is it really safe?
View moreAre percutaneous transluminal coronary angioplasty and coronary artery bypass grafting safe enough?
View moreAntidepressants and suicide among young women in Sweden 1999-2013
View moreA compromise too far: A review of Canadian cases of direct-to-consumer advertising regulation
View moreAn ISDB survey to assess the degree of transparency of drug regulatory agencies
View moreAn intelligent algorithm for assessing patient safety culture and adverse events voluntary reporting using PCA and ANFIS
View moreAll I have is a void: Women's perceptions of the benefits and side effects of ECT
View moreAlemtuzumab for relapsing multiple sclerosis in clinical practice: A four-year retrospective one-center study
View moreAffordability versus innovation: Is compulsory licensing the solution?
View moreAdverse pregnancy outcomes between the anti-malarial drugs: Is there a difference between the drugs recommended by World Health Organization? Results of a mixed treatment comparison analysis of randomized clinical trials and cohort studies
View moreAdverse event assessment methods in published trials of psychotropic drugs: Poor reporting and neglect of emerging safety concerns
View moreAdverse effects of aromatherapy: A systematic review of case reports and case series
View moreAdverse drug reactions to herbal and synthetic expectorants
View moreActions in response to drug safety signals arising from a spontaneous reporting system: Retrospective study in The Netherlands
View more